Cross-Sector entity
Meningitis B is most often covered alongside GSK, which appears in 3 of these 3 stories. Coverage clusters in pharma, which accounts for 2 of those 3, with the remainder spread across 1 other category. We currently track 3 Cross-Sector stories that mention Meningitis B, all published on March 17, 2026.
3 verified stories tracked
Last mentioned: Mar 17, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Meningitis B is most often covered alongside GSK, which appears in 3 of these 3 stories. Coverage clusters in pharma, which accounts for 2 of those 3, with the remainder spread across 1 other category. We currently track 3 Cross-Sector stories that mention Meningitis B, all published on March 17, 2026. Each carries 2.3 original sources on average.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Meningitis B. Shared-story counts are live from our verified record — not editorial picks.
Mass Vaccination
UKHSA and NHS begin large-scale immunization drive using the Bexsero vaccine.
Strain Confirmation
Laboratory results confirm Meningitis B as the causative agent in two fatal cases.
UKHSA Briefing
Health chiefs describe the outbreak as 'explosive' and 'unprecedented' in national alerts.
Initial Reports
First cases of severe meningitis reported among students at the University of Kent.
Outbreak Detected
Initial cases reported with severe symptoms; public health investigation launched.
Vaccine Integration
UK becomes first to add MenB vaccine (Bexsero) to routine infant schedule.
UK health officials are responding to a severe Meningitis B outbreak at the University of Kent that has left two students dead and 11 others seriously ill. Described as "explosive" and "unprecedented," the cluster has triggered an urgent mass vaccination campaign and heightened surveillance across the region.
Health authorities have confirmed Meningitis B as the strain responsible for a recent outbreak resulting in two fatalities. The confirmation is expected to intensify the focus on regional vaccination coverage and the efficacy of current immunization protocols against emerging clusters.
Health authorities have confirmed that Meningitis B is the strain responsible for a recent outbreak that has resulted in two fatalities. The identification triggers immediate public health protocols, including targeted vaccination and antibiotic prophylaxis for close contacts to prevent further spread.
Source: eadt.co.uk · lancashiretelegraph.co.uk
